Thalamic, hippocampal, amygdalar and brainstem long-term changes in schizophrenia co-localised with normative neurotransmitter distributions
- 1University of Seville
Abstract
BackgroundSchizophrenia Spectrum Disorders (SSD) is associated with spatially heterogeneous structural abnormalities across distributed brain systems, but the longitudinal evolution and neurochemical context of subcortical subregional changes remain poorly understood. We investigated longitudinal volume changes across thalamic, hippocampal, amygdalar, and brainstem subregions and their relationships with clinical characteristics and normative neurotransmitter distribution.
MethodsA total of 357 SSD individuals with first-episode and 196 healthy controls were included. Clinical assessments were performed at baseline and at 1, 3, 5, 10, 15, and 20 years of follow-up. Using T1-weighted structural MRI, subregional volumes were quantified across the thalamus, hippocampus, amygdala, and brainstem. We examined baseline group differences, longitudinal volume changes, and associations with clinical variables, including symptom severity. Spatial patterns of regional associations were compared with normative maps of neurotransmitter receptor and transporter distributions.
ResultsPatients showed heterogeneous structural alterations across the examined subcortical subregions. The hippocampus showed prominent early volume deficits in specific subfields and demonstrated a strong association with antipsychotic medication doses. Amygdalar volumetric reductions were more widespread and were strongly associated with positive symptom severity. Localised structural abnormalities were also observed in the thalamus and brainstem, although these showed weak associations with clinical symptomatology. The spatial co-location of normative neurotransmitter maps with the structural and clinical associations revealed distinct overlapping with dopaminergic, GABAergic, glutamatergic, serotonergic and cholinergic systems.
ConclusionsLongitudinal structural alterations in SSD showed marked anatomical heterogeneity across thalamic, limbic, and brainstem systems. Their spatial correspondence with normative neurochemical architecture suggests that regional and subregional structural vulnerability and clinical heterogeneity may be organized along distinct, partially overlapping neurotransmitter profiles.
Related
- Gray matter alterations and their atlas-based spatial associations with neurotransmitter distributions in isolated REM sleep behavior disorder
- Understanding the role of dysfunctional hippocampal-parahippocampal representations of space in schizophrenia
- Influence of exogenous glucagon‐like peptide 2 on mechanisms of enteric neurotransmitter‐mediated vasorelaxation in the isolated bovine mesenteric artery and vein
- Altered brain activity and childhood trauma associate with gene and neurotransmitter patterns in transgender women with gender dysphoria
- Aluminum Chloride-Induced Planarian Model with Cognitive Impairments Through Neuronal Damage, Neurotransmitter Imbalance, Apoptosis, and Oxidative Stress
BibTeX
@misc{alemanmorillo2026thalamic,
title = {{Thalamic, hippocampal, amygdalar and brainstem long-term changes in schizophrenia co-localised with normative neurotransmitter distributions}},
author = {C. Aleman-Morillo and N. Garcia-San-Martin and R. A. Bethlehem and P. Segura and C. Gomez and A. Pasquini and P. Salguero-Quiros and M. Munoz-Caracuel and R. Ayesa-Arriola and J. Vazquez-Bourgon and J. Suckling and M. Ruiz-Veguilla and B. Crespo-Facorro and R. Romero-Garcia},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.21.26363537},
url = {https://www.medrxiv.org/content/10.64898/2026.09.21.26363537v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Thalamic, hippocampal, amygdalar and brainstem long-term changes in schizophrenia co-localised with normative neurotransmitter distributions
AU - C. Aleman-Morillo
AU - N. Garcia-San-Martin
AU - R. A. Bethlehem
AU - P. Segura
AU - C. Gomez
AU - A. Pasquini
AU - P. Salguero-Quiros
AU - M. Munoz-Caracuel
AU - R. Ayesa-Arriola
AU - J. Vazquez-Bourgon
AU - J. Suckling
AU - M. Ruiz-Veguilla
AU - B. Crespo-Facorro
AU - R. Romero-Garcia
PY - 2026
DA - 2026/09/21
PB - medRxiv
DO - 10.64898/2026.09.21.26363537
UR - https://www.medrxiv.org/content/10.64898/2026.09.21.26363537v1
AB - BackgroundSchizophrenia Spectrum Disorders (SSD) is associated with spatially heterogeneous structural abnormalities across distributed brain systems, but the longitudinal evolution and neurochemical context of subcortical subregional changes remain poorly understood. We investigated longitudinal volume changes across thalamic, hippocampal, amygdalar, and brainstem subregions and their relationships with clinical characteristics and normative neurotransmitter distribution. MethodsA total of 357 SSD individuals with first-episode and 196 healthy controls were included. Clinical assessments were performed at baseline and at 1, 3, 5, 10, 15, and 20 years of follow-up. Using T1-weighted structural MRI, subregional volumes were quantified across the thalamus, hippocampus, amygdala, and brainstem. We examined baseline group differences, longitudinal volume changes, and associations with clinical variables, including symptom severity. Spatial patterns of regional associations were compared with normative maps of neurotransmitter receptor and transporter distributions. ResultsPatients showed heterogeneous structural alterations across the examined subcortical subregions. The hippocampus showed prominent early volume deficits in specific subfields and demonstrated a strong association with antipsychotic medication doses. Amygdalar volumetric reductions were more widespread and were strongly associated with positive symptom severity. Localised structural abnormalities were also observed in the thalamus and brainstem, although these showed weak associations with clinical symptomatology. The spatial co-location of normative neurotransmitter maps with the structural and clinical associations revealed distinct overlapping with dopaminergic, GABAergic, glutamatergic, serotonergic and cholinergic systems. ConclusionsLongitudinal structural alterations in SSD showed marked anatomical heterogeneity across thalamic, limbic, and brainstem systems. Their spatial correspondence with normative neurochemical architecture suggests that regional and subregional structural vulnerability and clinical heterogeneity may be organized along distinct, partially overlapping neurotransmitter profiles.
ER -